Compare LXEO & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LXEO | VEL |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.3M | 755.4M |
| IPO Year | 2023 | 2020 |
| Metric | LXEO | VEL |
|---|---|---|
| Price | $7.65 | $19.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $18.60 | ★ $21.75 |
| AVG Volume (30 Days) | ★ 1.3M | 127.3K |
| Earning Date | 11-05-2025 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.26 |
| EPS | N/A | ★ 2.43 |
| Revenue | N/A | ★ $229,360,000.00 |
| Revenue This Year | N/A | $5.75 |
| Revenue Next Year | N/A | $27.31 |
| P/E Ratio | ★ N/A | $8.09 |
| Revenue Growth | N/A | ★ 116.81 |
| 52 Week Low | $1.45 | $16.12 |
| 52 Week High | $10.99 | $21.40 |
| Indicator | LXEO | VEL |
|---|---|---|
| Relative Strength Index (RSI) | 39.22 | 56.03 |
| Support Level | $7.02 | $18.98 |
| Resistance Level | $10.75 | $19.88 |
| Average True Range (ATR) | 0.84 | 0.62 |
| MACD | -0.24 | 0.06 |
| Stochastic Oscillator | 18.70 | 49.26 |
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.